RESEARCH TRIANGLE PARK, NC – IQVIA™ (NYSE:IQV), has published its 2023 Environmental, Social and Governance (ESG) Report. The annual report provides a detailed account of the organization’s focus on reducing… Read More
Submission supported by positive results of a Phase III study showing immune response and tolerability in adults aged 50-59 Adults aged 50 and above with underlying medical conditions are at… Read More
Biktarvy Now First and Only INSTI-Based Single-Tablet Regimen That is FDA Approved and DHHS Guideline Recommended for People Who are Virologically Suppressed with M184V/I Resistance M184V/I One of the Most… Read More
If approved, KALYDECO® will be the first and only medicine approved in Europe to treat the underlying cause of cystic fibrosis in babies as young as 1 month with specific mutations in… Read More
PICKERING, ON – LifeLabs, Canada’s most trusted medical laboratory, is pleased to announce the official grand opening of our newest Patient Service Centre (PSC) in North Pickering, Ontario. Situated at… Read More
